首页 | 本学科首页   官方微博 | 高级检索  
     


Case of B-Cell Lymphoma with Rearrangement of the BCL1, BCL2, BCL6, and c-MYC Genes
Authors:Keiki?Kawakami  author-information"  >  author-information__contact u-icon-before"  >  mailto:kawakei@cocoa.ocn.ne.jp"   title="  kawakei@cocoa.ocn.ne.jp"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Setsuko?Miyanishi,Takashi?Sonoki,Shigeo?Nakamura,Kenichi?Nomura,Masafumi?Taniwaki,Tetsuya?Murata,Shigenori?Kadowaki,Norimitsu?Kadowaki,Ikuo?Miura
Affiliation:Division of Hematology, Suzuka General Hospital, Suzuka-shi, Mie, Japan. Kawakei@cocoa.ocn.ne.jp
Abstract:We managed a peculiar case of lymphoma showing immunohistochemical overexpression of cyclin D1. At initial examination the patient had meningeal lymphomatosis and general lymphadenopathy. Histologic examination of biopsy specimens of inguinal lymph nodes showed tumor cells and vague nodular growth resembling lymphoblasts. The results of flow cytometric analysis were positive for CD10, CD20, CD103, and immunoglobulin G (IgG) and Ig kappa and were negative for CD5, CD23, and terminal deoxynucleotidyl transferase activity. Results of immunohistochemical analysis of paraffin-embedded specimens were positive for cyclin D1 and Bcl2 in the tumor cells. Sixty percent of tumor cells had positive results for MIB1/Ki67. Cytogenetic and molecular studies revealed tumor cells simultaneously had t(14;18)(q32;q21), t(11;22)(q13;q11), t(8;14)(q24;q32), and t(3;14)(q27;q32) with the rearrangement of BCL1, BCL2, BCL6, and c-MYC genes. Lymphadenopathy showed a quick and complete response to doxorubicin-containing systemic chemotherapy with rituximab, but the central nervous system disease progressed and killed the patient.
Keywords:Malignant lymphoma   BCL1    BCL2    BCL6    c-MYC
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号